Opioid-Induced Constipation (OIC) Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 31 pages | ID: O8579753B08EN
VPAResearch

Abstracts

Opioid-Induced Constipation (OIC) ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Opioid-Induced Constipation (OIC) disease clinical trials. The research work analyzes the ongoing Opioid-Induced Constipation (OIC) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Opioid-Induced Constipation (OIC) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Opioid-Induced Constipation (OIC) clinical trials.

Scope of the Report-

• Ongoing Opioid-Induced Constipation (OIC) clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Opioid-Induced Constipation (OIC)
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Opioid-Induced Constipation (OIC) clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Opioid-Induced Constipation (OIC) Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Opioid-Induced Constipation (OIC) Trials by Phase
3.2 Ongoing Opioid-Induced Constipation (OIC) Trials by Type
3.3 Ongoing Opioid-Induced Constipation (OIC) Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Opioid-Induced Constipation (OIC) Trials
4.2 Top 10 Countries conducting Opioid-Induced Constipation (OIC) Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Opioid-Induced Constipation (OIC) Trials by Sponsor Type
5.2 Opioid-Induced Constipation (OIC) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Opioid-Induced Constipation (OIC) Trials by year
6.2 Subjects Recruited for Opioid-Induced Constipation (OIC) Trials by Phase
6.3 Subjects Recruited for Opioid-Induced Constipation (OIC) Trials by Trial Type
6.4 Subjects Recruited for Opioid-Induced Constipation (OIC) Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Opioid-Induced Constipation (OIC) Trials- Phase
7.2 Ongoing Opioid-Induced Constipation (OIC) Trials- Phase
7.3 Ongoing Opioid-Induced Constipation (OIC) Trials- Phase
7.4 Ongoing Opioid-Induced Constipation (OIC) Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Opioid-Induced Constipation (OIC)- Clinical Trials by Country
Figure 2: Opioid-Induced Constipation (OIC)- Clinical Trials by Phase of Development, 2018
Figure 3: Opioid-Induced Constipation (OIC)- Clinical Trials by Status, 2018
Figure 4: Opioid-Induced Constipation (OIC)- Clinical Trials by Type, 2018
Figure 5: Opioid-Induced Constipation (OIC)- Clinical Trials Split by Region, 2000-2018
Figure 6: Opioid-Induced Constipation (OIC)- Clinical Trials by Type of Economy, 2018
Figure 7: Opioid-Induced Constipation (OIC)- Enrolment by Phase, 2018
Figure 8: Opioid-Induced Constipation (OIC)- Enrolment by Trial Type, 2018
Figure 9: Opioid-Induced Constipation (OIC)- Enrolment by Recruitment Status, 2018
Figure 10: Opioid-Induced Constipation (OIC)- Clinical Trials by Sponsor Type, 2018
Figure 11: Opioid-Induced Constipation (OIC)- Enrolment by Type of Sponsors
Figure 12: Opioid-Induced Constipation (OIC)- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Opioid-Induced Constipation (OIC)- Clinical Trials by Sponsor Type, 2018
Table 2: Opioid-Induced Constipation (OIC)- Clinical Trials by Economy Type, 2018
Table 3: Opioid-Induced Constipation (OIC)- Clinical Trials by Region, 2018
Table 4: Opioid-Induced Constipation (OIC)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Opioid-Induced Constipation (OIC)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Opioid-Induced Constipation (OIC)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Opioid-Induced Constipation (OIC)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Opioid-Induced Constipation (OIC)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Opioid-Induced Constipation (OIC)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company